June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
MicroRNA-19a enhances axon regeneration in retinal ganglion cells
Author Affiliations & Notes
  • Heather Kayew Mak
    Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong
  • Xu Cao
    Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong
  • Jasmine Sum Yee Yung
    Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong
  • Heidi Ng
    Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong
  • Tin Lap Lee
    School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong
  • Christopher Kai-Shun Leung
    Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong
  • Footnotes
    Commercial Relationships   Heather Mak, None; Xu Cao, None; Jasmine Yung, None; Heidi Ng, None; Tin Lap Lee, None; Christopher Leung, Alcon (C), Alcon (R), Allergan (C), Allergan (R), Carl Zeiss Meditec (F), Carl Zeiss Meditec (P), Glaukos (F), Global Vision (R), Lumenis (R), Merck (R), Novartis (R), Oculus (F), Optovue (F), Santen (R), Tomey (F), Tomey (R), Topcon (F)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 2600. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Heather Kayew Mak, Xu Cao, Jasmine Sum Yee Yung, Heidi Ng, Tin Lap Lee, Christopher Kai-Shun Leung; MicroRNA-19a enhances axon regeneration in retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 2017;58(8):2600.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Retinal ganglion cells (RGCs) lose capacity to regenerate axons in early postnatal age. While a number of transcription factors and signaling molecules have been implicated to the loss of regenerative potential of RGC axon, their upstream regulators are largely unstudied. We investigated the association between developmental decline of RGC regenerative potential and age-related changes in microRNA (miRNA) expression and demonstrated that miRNA-19a augments RGC axon regenerative capacity after optic nerve (ON) injury.

Methods : Microarray was performed on purified RGCs from Sprague Dawley (SD) rats at embryonic day 21 (E21), postnatal day 6 (P6), postnatal day 14 (P14), and postnatal day 30 (P30) to study the changes in miRNA expression. Age-related change in miRNA expression was confirmed by RT-PCR. RGC axon length and growth rate from SD rats and human adult donor eyes were measured by microfluidic chambers (MFCs) and time-lapse imaging, respectively, after transduction of AAV-miR-19a-eGFP or control. C57BL/6 mice were intravitreally injected with AAV-miR-19a-eGFP or control 2 weeks before ON crush and the number of regenerating axons was measured 4 weeks after crush.

Results : Microarray revealed 65 miRNAs to be significantly downregulated from E21 to P30 in which RT-PCR confirmed that miR-19a decreased 55-fold from E21 to P30 (p<0.001). miR-19a increased RGC axon length in MFCs by 2.62- and 2.01-fold on 14 and 21 days in vitro, respectively (p<0.006), and accelerated axon regenerative growth rate by 2.46-fold (p<0.001) in time-lapse imaging compared with controls. Human adult RGCs with miR-19a had longer axon and total neurite lengths by 26.7% (p=0.025) and 59.8% (p<0.001), respectively, compared with controls. Mice with miR-19a had 2-folds more regenerated axons (p=0.004) at every 0.5 mm starting 1 mm from the ON crush site.

Conclusions : There is an age-related change of miRNA levels in RGCs, which coincides with the age-related decline in axon growth potential. We showed that the loss of axon regenerative potential can be partially restored by upregulating miR-19a in RGCs in vitro and in vivo, presenting a new potential therapeutic approach to resuscitate age-related loss of axon growth ability.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

 

Heirarchical cluster of E21, P6, P14, and P30 RGC miRNA and 65 miRNAs significantly downregulated from E21 to P30.

Heirarchical cluster of E21, P6, P14, and P30 RGC miRNA and 65 miRNAs significantly downregulated from E21 to P30.

 

ON sections after crush with AAV-miR-19a-eGFP (top) or AAV-eGFP (bottom), and estimated number of regenerated axons.

ON sections after crush with AAV-miR-19a-eGFP (top) or AAV-eGFP (bottom), and estimated number of regenerated axons.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×